6-keto-Prostaglandin F1a

From NuGOwiki

Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

6-keto-Prostaglandin F1a
2D structure for 6-keto-Prostaglandin F1a
Chemical Name 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]-6-oxoheptanoic acid
Chemical Formula C20H34O6
CAS Number 58962-34-8
Chemical Information HMDB02886
Biochemical Taxonomy

  • Prostanoids

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways Not Available
Biofluid Location

  • Blood
  • Urine

Tissue Location

  • Placenta
  • Platelet
  • Adipose Tissue

Normal Biofluid Concentrations

  • Blood: 0.000081 (0.0-0.00016) umol/L
  • Urine: 0.00000026 (0.00000021-0.00000032) umol/mmol creatinine

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • Resuscitated patients
  • Rheumatoid arthritis

Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations

  • Blood (Resuscitated patients): 0.00074 +/- 0.00017 umol/L
  • Urine (Rheumatoid arthritis): 0.00000035 (0.00000033-0.00000037) umol/mmol creatinine

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
6-keto-Prostaglandin F1a is the physiologically active and stable metabolite of prostacyclin. (A prostaglandin found in nearly all mammalian tissue that is a powerful vasodilator and inhibits platelet aggregation; it is biosynthesized enzymatically from prostaglandin endoperoxides in human vascular tissue; the sodium salt has been also used to treat primary pulmonary hypertension (Hypertension, Pulmonary). A delayed and prolonged increase in 6-keto-PGF1 alpha is reported in animals with septic shock, i.e., those with fecal peritonitis or cecal ligation. 6-keto-Prostaglandin F1a plasma levels has been found increased in patients with epidemic hemorrhagic fever, in patients with acute obstructive suppurative cholangitis, in patients with gynecologic cancer and has significant correlation with the level of high density lipoprotein cholesterol in plasma. (PMID 1976492, 2298410, 2379443, 2111556)

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines

  • Resuscitated patients
  • Rheumatoid arthritis

Other (Monogenic) Disorders

guidelines


Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines